comprehensive -WSS

comprehensive

author：knowledge 2025-08-19 18:05:17 - browse：26156

Adam's take main illustration — Molly Ferguson/STAT

Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question: Does early success of the drug, called Relyvrio, make it more complicated, perhaps impossible, to pull it from the market if we find out next year that it doesn’t work?

On Monday night, Amylyx said Relyvrio sales totaled $22 million in 2022 — a period that covers slightly more than one calendar quarter given the drug’s U.S. approval last September. The company said approximately 1,300 ALS patients were on Relyvrio at the end of December, and it expects that number to at least double by the end of the first quarter.

“We’re probably going to double, closer to triple, our revenue in Q1,” said James Frates, Amylyx’s chief financial officer, speaking on Monday night’s conference call.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

knowledge

WSS

Climate activists disrupt London Pride march to protest corporate sponsorship

Francis Collins on trust in science and how Covid communications failed

Does Medicare's free annual wellness visit do any good?

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Readout Newsletter: Merck, J&J, and long Covid

Think you might have Covid

explore

comprehensive

entertainment

Heart attack and stroke risk calculators need revising

eGenesis tests gene

Wildfire smoke exposes gaps in outdoor worker protections

The tragedy of Johnson & Johnson’s Covid vaccine

ChatGPT in medicine: STAT answers readers' burning questions

Francis Collins on trust in science and how Covid communications failed

New air purifier tech could be key to improving indoor air quality

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Moonlake's readout produced a cash windfall. Risks remain

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Wikipedia

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

The tragedy of Johnson & Johnson’s Covid vaccine

Parkland mass shooting to be reenacted for lawsuit

'Cuddling' is just what the doctor ordered for a 200

Lifetime voting ban for felony convictions struck down in Mississippi

Calls for Trump's election interference trial to be televised part of long debate

entertainment

knowledge

explore

focus